Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
New Egyptian Journal of Medicine [The]. 2005; 32 (2): 99-105
en Inglés | IMEMR | ID: emr-73800

RESUMEN

Studies of pre-emptive analgesia in humans have shown conflicting results. This prospective, randomized, double- blind, controlled study was designed to test the hypothesis that a reduction in postoperative morphine consumption can be achieved by tramadol administered after induction of anaesthesia. Ninety Patients were allocated randomly to receive i.v. tramadol [1 mg kgBiops -1] [Group T], morphine [0.1 mg kg -1] [Group M] or saline 2 ml [Group S] after induction of anaesthesia. At pentoneal closure, a standardized [0.1 mg kg -1] morphine loading dose was given to all patients for postoperatrive pain management. Patients were allowed to use a patient-controlled analgesia [PCA] device giving bolus doses of morphine 0.025 mg kg -1. Discomfort, sedation, pain scores, cumulative morphine consumption, and side effects were recorded at 1, 2, 6, 12 and 24 h after the start of PCA. There were no significant differences between groups in mean pain, discomfort, and sedation scores at any study period. Cumulative morphine consumption was significantly lower in Group M at 12 and 24 h after starting the PCA than in Group S. In Group T, it was lower only after 24 h [28% less in Group M and 17% less in Group T; P < 0.017]. There were no significant differences in morphine consumption between Groups T and M. Conclusions. Tramadol [1 mg kg -1], administered after induction of anaesthesia, offered equivalent postoperative pain relief, and similar recovery times and postoperative PCA morphine consumption compared with giving morphine 0.1 mg kg -1. These results also suggest that presurgical exposure to systemic opioid analgesia may not result in clinically significant benefits


Asunto(s)
Humanos , Masculino , Femenino , Dolor Postoperatorio/tratamiento farmacológico , Tramadol , Morfina , Estudios Prospectivos , Resultado del Tratamiento
2.
Medical Journal of Teaching Hospitals and Institutes [The]. 2005; (65): 7-12
en Inglés | IMEMR | ID: emr-73251

RESUMEN

We evaluated the effect of low-dose bupivacaine plus fentanyl administered intrathecally in elderly patients undergoing transurethral prostatectomy. Patients were randomly assigned to one of two groups. Group F received plain bupivacaine 4 mg with 25 mg of fentanyl and sterile water to a total of l.5 ml, and Group B received only 0.5% plain bupivacaine 7.5 mg for spinal anaesthesia. Sensory block was adequate for surgery in all patients. The mean level of motor block was higher and the duration of motor block was longer in Group B [p < 0.0001]. Hypotension and shivering were significantly more common in Group B [p < 0.05]. The addition of fentanyl 25 mg to plain bupivacaine 4 mg provides adequate analgesia for transurethral prostatectomy with fever side-effects in elderly patients when compared with the conventional dose of bupivacaine


Asunto(s)
Humanos , Masculino , Bupivacaína/efectos adversos , Fentanilo/efectos adversos , Resección Transuretral de la Próstata , Combinación de Medicamentos/efectos adversos , Complicaciones Posoperatorias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA